Delivery Order SPE2DB22D3016-SPE2DB24FBEK0

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,917.81 firm-fixed-price delivery order is for the supply of Victoza 2-Pak 18 mg/3 ml pens. The award is not associated with any set-aside program. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for delivering a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,565.72 Firm Fixed Price Delivery Order contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medical products. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,118.87 delivery order is for the supply of Victoza 3-Pak 18 mg/3 ml pen medication. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a comprehensive range of medical commodities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,745.48, is for the delivery of Victoza 3-Pak 18 mg/3 ml pens. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999 IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml. The contract has a ceiling value of $3,531.45 and a completion date of March 18, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC is valued at up to...
This federal contract award, valued at $4,112.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Victoza 3-pak 18 mg/3 ml pen 3 ml, a prescription medication. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $15,737.53, was granted to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract has an ultimate completion date of August 27, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award, valued at $4,455.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML, a specialty pharmaceutical product, with a period of performance through November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $4,387.67, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medical products. The contract has an ultimate completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,764.76 firm-fixed-price delivery order is for the supply of Victoza 2-Pak 18 mg/3 mL pens. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBEK0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Victoza 3-Pak 18 mg/3 ml pen medical products. The $4,237.74 firm-fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which covers a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation and is scheduled for completion by August 19, 2024.

Generated 11/15/24, 9:18 AM